These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6100600

  • 1. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK, Williams GH.
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [Abstract] [Full Text] [Related]

  • 2. Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors.
    Williams GH, Hollenberg NK.
    J Hypertens Suppl; 1985 Nov; 3(2):S81-7. PubMed ID: 3003304
    [Abstract] [Full Text] [Related]

  • 3. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK, Williams GH.
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [Abstract] [Full Text] [Related]

  • 4. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH, Moore TJ, Hollenberg NK.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The renin-angiotensin system and hypertension.
    Williams GH.
    Clin Exp Pharmacol Physiol Suppl; 1982 Jul; 7():31-40. PubMed ID: 6754184
    [Abstract] [Full Text] [Related]

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension.
    Williams GH, Moore TJ, Hollenberg NK.
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):423-47. PubMed ID: 1879402
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin and the renal circulation in hypertension.
    Hollenberg NK, Williams GH.
    Circulation; 1988 Jun; 77(6 Pt 2):I59-63. PubMed ID: 3286047
    [Abstract] [Full Text] [Related]

  • 14. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK.
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of kidney in hypertension.
    Tripathi S, Tripathi K.
    J Indian Med Assoc; 2003 Apr; 101(4):260-2, 264-5. PubMed ID: 12964647
    [Abstract] [Full Text] [Related]

  • 18. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y, Franco-Saenz R, Mulrow PJ.
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.